Angstrom Pharmaceuticals, Inc. (angstrom)

Oncology Corporate Profile

HQ Location

990 Highland Drive, Suite 110V
Solana Beach, CA 92075

Company Description

Angstrom Pharmaceuticals, Inc., a privately held pharmaceutical company headquartered in Solana Beach, California, is developing a new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies. Angstrom's lead product, A6 peptide, is in Phase 2 clinical development for ovarian cancer and chronic lymphocytic leukemia (CLL).


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
A6CD44 binding peptideChronic Lymphocytic Leukemia (CLL)II

View additional information on product candidates here »


Recent News Headlines

There are no news items to display